Epidemiology of hepatocellular carcinoma

Oncology

Volumn 78, Issue SUPPL. 1, 2010, Pages 7-10

  Sherman, Morris ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

Chronic hepatitis B; Chronic hepatitis C; Hepatocellular carcinoma

Indexed keywords

CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CHRONIC HEPATITIS; COHORT ANALYSIS; EUROPE; HEPATITIS B; HEPATITIS C; HUMAN; IMMIGRANT; IMMIGRATION; LIVER CELL CARCINOMA; NORTH AMERICA; PRIORITY JOURNAL; SHORT SURVEY;

CARCINOMA, HEPATOCELLULAR; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMANS; INCIDENCE; LIVER NEOPLASMS;

EID: 77954531753     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000315223     Document Type: Short Survey

References (28)

1. Bosch FX: Global epidemiology of hepatocellular carcinoma; in Okuda K, Tabor E (eds): Liver Cancer. New York, Churchill Livingston, 1997, pp 13-37.
2. Beasley RP, Hwang LY, Lin CC, Chien CS: Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22,700 men in Taiwan. Lancet 1981; 2: 1129-1133.
3. Sakuma K, Saitoh N, Kasai M, Jitsukawa H, Yoshino I, Yamaguchi M, Nobutomo K, Yamumi M, Tsuda F, Komazawa T, Nakamura T, Yoshida Y, Okuda K: Relative risks of death due to liver disease among Japanese male adults having various statuses for hepatitis B s and e antigen/antibody in serum: a prospective study. Hepatology 1988; 8: 1642-1646.
4. Villeneuve JP, Desrochers M, Infante-Rivard C, Willems B, Raymond G, Bourcier M, Côté J, Richer G: A long-term follow-up study of asymptomatic hepatitis B surface antigenpositive carriers in Montreal. Gastroenterology 1994; 106: 1000-1005.
5. McMahon BJ, Alberts SR, Wainwright RB, Bulkow L, Lanier AP: Hepatitis B-related sequelae. Prospective study of 1,400 hepatitis B surface antigen-positive Alaska native carriers. Arch Intern Med 1990; 150: 1051-1054.
6. Sherman M, Peltekian KM, Lee C: Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population. Hepatology 1995; 22: 432-438.
7. Fattovich G, Giustina G, Schalm SW, Hadziyannis S, Sanchez-Tapias J, Almasio P, Christensen E, Krogsgaard K, Degos F, Carneiro de Moura M, Solinas A, Noventa F, Realdi G: Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B. The EUROHEP Study Group on Hepatitis B Virus and Cirrhosis. Hepatology 1995; 21: 77-82.
8. Fattovich G, Giustina G, Degos F, Tremolada F, Diodati G, Almasio P, Nevens F, Solinas A, Mura D, Brouwer JT, Thomas H, Njapoum C, Casarin C, Bonetti P, Fuschi P, Basho J, Tocco A, Bhalla A, Galassini R, Noventa F, Schalm SW, Realdi G: Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 1997; 2: 463-472.
9. Bruix J, Barrera JM, Calvet X, Ercilla G, Costa J, Sanchez-Tapias JM, Ventura M, Vall M, Bruguera M, Bru C, Rodes J: Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatitis cirrhosis. Lancet 1989;ii:1004-1006.
10. Niederau C, Lange S, Heintges T, Erhardt A, Buschkamp M, Hürter D, Nawrocki M, Kruska L, Hensel F, Petry W, Häussinger D: Prognosis of chronic hepatitis C: results of a large, prospective cohort study. Hepatology 1998; 28: 1687-1695.
11. Benvegnù L, Fattovich G, Noventa F, Tremolada F, Chemello L, Cecchetto A, Alberti A: Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study. Cancer 1994; 74: 2442-2448.
12. Chiesa R, Donato F, Tagger A, Favret M, Ribero ML, Nardi G, Gelatti U, Bucella E, Tomasi E, Portolani N, Bonetti M, Bettini L, Pelizzari G, Salmi A, Savio A, Garatti M, Callea F: Etiology of hepatocellular carcinoma in Italian patients with and without cirrhosis. Cancer Epidemiol Biomarkers Prev 2000; 9: 213.
13. Fargion S, Fracanzani AL, Piperno A, Braga M, D'Alba R, Ronchi G, Fiorelli G: Prognostic factors for hepatocellular carcinoma in genetic hemochromatosis. Hepatology 1994; 20: 1426-1431.
14. Caballeria L, Pares A, Castells A, Gines A, Bru C, Rodes J: Hepatocellular carcinoma in primary biliary cirrhosis: similar incidence to that in hepatitis C virus-related cirrhosis. Am J Gastroenterol 2001; 96: 1160-1163.
15. Fattovich G, Brollo L, Giustina G, Noventa F, Pontisso P, Alberti A, Realdi G, Ruol A: Natural history and prognostic factors for chronic hepatitis type B. Gut 1991; 32: 294-298.
16. Simonetti RG, Camma C, Fiorello F, Politi F, D'Amico G, Pagliaro L: Hepatocellular carcinoma a worldwide problem and the major risk factor. Dig Dis Sci 1991; 36: 962-972.
17. El-Serag H, Mason AC: Rising incidence of hepatocellular carcinoma in the United states. N Engl J Med 1999; 340: 745-750. (Pubitemid 29114292)
18. Okuda K, Fujimoto I, Hanai A, Urano Y: Changing incidence of hepatocellular carcinoma in Japan. Cancer Res 1987; 47: 4967-4972.
19. Taylor-Robinson SD, Foster GR, Arora S, Hargreaves S, Thomas HC: Increase in primary liver cancer in the UK 1979-1974. Lancet 1997; 350: 1142-1143.
20. Deuffic S, Poynard T, Buffat L, Valleron AJ: Trends in primary liver cancer. Lancet 1998; 351: 214-215.
21. Stroffolini T, Andreone P, Andriulli A, Ascione A, Craxi A, Chiaramonte M, Galante D, Manghisi OG, Mazzanti R, Medaglia C, Pilleri G, Rapaccini GL, Simonetti RG, Taliani G, Tosti ME, Villa E, Gasbarrini G: Characteristics of hepatocellular carcinoma in Italy. J Hepatol 1998; 29: 944-952.
22. Madzime S, Adem M, Mahomed K, Woelk GB, Mudzamiri S, Williams MA: Hepatitis B virus infection among pregnant women delivering at Harare Maternity Hospital, Harare Zimbabwe, 1996 to 1997. Cent Afr J Med 1999; 45: 195-198.
23. Ahmed SD, Cuevas LE, Brabin BJ, Kazembe P, Broadhead R, Verhoeff FH, Hart CA: Seroprevalence of hepatitis B and C and HIV in Malawian pregnant women. J Infect 1998; 37: 248-251.
24. Anderson KE, Stevens CE, Tsuei JJ, Lee WC, Sun SC, Beasley P: Hepatitis B antigen in infants born to mothers with chronic hepatitis B antigenemia in Taiwan. Am J Dis Child 1975; 129: 1389-1392.
25. Beasley RP, Trepo C, Stevens CE, Szmuness W: The e antigen and vertical transmission of hepatitis B surface antigen. Am J Epidemiol 1977; 105: 94-98.
26. Yu MW, Chang HC, Liaw YF, Lin SM, Lee SD, Liu CJ, Chen PJ, Hsiao TJ, Lee PH, Chen CJ: Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives. J Natl Cancer Inst 2000; 92: 1159-1164.
27. Guadagnino V, Stroffolini T, Rapicetta M, Costantino A, Kondili LA, Menniti-Ippolito F, Caroleo B, Costa C, Griffo G, Loiacono L, Pisani V, Focà A, Piazza M: Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy. Hepatology 1997; 26: 1006-1011.
28. Guadagnino V, Stroffolini T, Rapicetta M, Costantino A, Kondili LA, Menniti-Ippolito F, Caroleo B, Costa C, Griffo G, Loiacono L, Pisani V, Focà A, Piazza M: Hepatitis C virus (HCV) infection in a community in the Nile Delta: population description and HCV prevalence. Hepatology 2001; 32: 111-115.